-
Company Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Frazier Lifesciences Acquisition
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 375.55 k | 375.55 k | 375.55 k | 375.55 k | 375.55 k | 375.55 k |
Cash burn (monthly) | 79.97 k | 21.67 k | 764.53 k | 423.63 k | 79.97 k | 17.92 k |
Cash used (since last report) | 2.34 mm | 634.81 k | 22.40 mm | 12.41 mm | 2.34 mm | 524.96 k |
Cash remaining | -1.97 mm | -259.26 k | -22.02 mm | -12.03 mm | -1.97 mm | -149.41 k |
Runway (months of cash) | -24.6 | -12.0 | -28.8 | -28.4 | -24.6 | -8.3 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 5.07 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Morningside Venture Investments | 5.07 mm | $0.00 |